| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,254,197 | 1,039,944 | 853,436 | 1,126,509 | | Cost of Revenue | 615,349 | 518,674 | 446,277 | 557,797 | | | Gross Profit | 638,848 | 521,270 | 407,159 | 568,712 | | | Operating Expenses | | Research Development | 391,170 | 374,770 | 372,724 | 382,666 | | Selling General and Administrative | 192,480 | 127,410 | 125,048 | 147,213 | | Non Recurring | (37,594) | 3,302 | 8,261 | 200,943 | | Others | 4,159 | 4,139 | 4,159 | 2,842 | | | | Total Operating Expenses | 550,215 | 509,621 | 510,192 | 733,664 | | | | Operating Income or Loss | 88,633 | 11,649 | (103,033) | (164,952) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,800 | 5,005 | 6,044 | 8,189 | | Earnings Before Interest And Taxes | 91,433 | 16,654 | (96,989) | (156,763) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 91,433 | 16,654 | (96,989) | (156,763) | | Income Tax Expense | 6,837 | 3,253 | (5,049) | 2,452 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 84,596 | 13,401 | (91,940) | (159,215) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 84,596 | 13,401 | (91,940) | (159,215) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $84,596 | $13,401 | ($91,940) | ($159,215) |
|
0.22% Nasdaq 
Income Statement
